Advertisement

Topics

Phil Erlanger Research Co., Inc. Company Profile

21:02 EDT 22nd June 2018 | BioPortfolio

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data, enabling Phil Erlanger Research to offer independent, value-added data and analysis on over 6000 equity issues, 139 industry groups and 18 sectors. Following his experience as Advest 's Chief Technical Analyst, and his 5 year tenure as Senior Technical Analyst for Fidelity Management & Research Co. , Inc., Philip B. Erlanger formed his own company with the goal of providing high quality, unique information and research.

Location

Maynard
Massachusetts
United States of America


News Articles [72 Associated News Articles listed on BioPortfolio]

Vice-Admiral James P. Phil Wisecup (Ret.) Appointed to Kyield Board of Directors

Phil graduated from the U.S. Naval Academyin 1977.  In 2008 he became the 52nd President of the US Naval War Collegeand left active Read more...

Zilliant Names Phil Fraher as Chief Financial Officer

"Phil has an excellent track record advising fast-growth organizations and we're excited to welcome him to the company," said Zilliant CEO Greg Peters. "I'm Read more...

Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Phil Coelho, chief technology officer of the Com...

Vermont Senate Passes Bill to Make Marijuana Legal for Adults; Gov. Phil Scott Has Pledged to Sign

MONTPELIER, Vt. - January 10, 2018 (Investorideas.com Newswire) A bill that would make marijuana legal for adults in Vermont received final approval on Wednesday from the Vermont Senate and will soon ...

Illumina Picks Genomic Health’s Phil Febbo for Chief Medical Officer

Illumina (NASDAQ: ILMN) has appointed Phil Febbo to serve as chief medical officer of the San Diego genomics technologies company. Febbo most recently worked as chief medical officer of Redwood City, ...

Dr Phil Jones to join BioAscent as new CSO

BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q1 2018 Results - Earnings Call Transcript

Neurologist Paints a Sensitive View of Old Age in Independent Film

(MedPage Today) -- An elderly physician learns to redefine himself in 'Abe & Phil's Last Poker Game'

PubMed Articles [624 Associated PubMed Articles listed on BioPortfolio]

Research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust.

Meta-research is research about research. Meta-research may not be as click-worthy as a meta-pug-a pug dog dressed up in a pug costume-but it is crucial to understanding research. A particularly valua...

UK's first NHS high-energy proton beam facility.

With the UK's first high-energy Proton Beam Therapy Centre set to open next year at Manchester's The Christie, young patients with head and neck tumours, cancers close to the skull or spine, or a vari...

A consensus statement on how to conduct inclusive health research.

The active involvement of people with intellectual disabilities in research, or inclusive research, is relatively common. However, inclusive health research is less common, even though it is expected ...

Improving the process of research ethics review.

Research Ethics Boards, or Institutional Review Boards, protect the safety and welfare of human research participants. These bodies are responsible for providing an independent evaluation of proposed ...

Is the Right Research Being Conducted to Advance Knowledge about Breast Reconstruction? An Analysis of the Research Pipeline.

It has been estimated that up to 85 percent of research is of limited value or wasted, in part because of the wrong research questions being addressed. In this study, the authors identified research g...

Clinical Trials [1045 Associated Clinical Trials listed on BioPortfolio]

PHIL in the Treatment of Intracranial dAVF.

This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment. In this study, all patients with qualify...

PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation (cAVM)

The primary objective of this study is to assess the efficacy and safety of PHIL® liquid embolic agent in endovascular embolization of cerebral arteriovenous malformations.

PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF

The primary objective of this study is to demonstrate the safety and efficacy of the PHIL® liquid in endovascular treatment of dural arteriovenous fistula.

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the cells of the body. Because the genes are damaged, the body is unable to produce a group of protei...

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the body's cells. When genes are damaged, the body may be unable to produce a group of proteins, call...

Companies [1034 Associated Companies listed on BioPortfolio]

Phil Erlanger Research Co., Inc.

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data,...

Purple Heart Injury Laboratories

PHIL is a Defense Medicine™ incubator that supports the development of new technologies and therapies for healing battlefield injuries. PHIL’s objective is to become the...

Phil Inc.

Phil is an end-to-end prescription management service providing a convenient alternative to traditional pharmaceutical management. Through its desktop website and mobile app, Phil...

Phil Ellis Associates, Inc.

Phil Ellis Associates, Inc. is a professional search and recruiting firm specializing in the pharmaceutical, medical device, diagnostic, biomedical and allied industries and operates under the guidanc...

ValueMedics Research, LLC

Jonothan C. Tierce, C.Phil., and Elisabeth H. Hazard, Ph.D., formed ValueMedics in 2003. The initial staff was made up of the Health Economics, Outcomes Research, Pricing and Market Access unit of the...

More Information about "Phil Erlanger Research Co., Inc." on BioPortfolio

We have published hundreds of Phil Erlanger Research Co., Inc. news stories on BioPortfolio along with dozens of Phil Erlanger Research Co., Inc. Clinical Trials and PubMed Articles about Phil Erlanger Research Co., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phil Erlanger Research Co., Inc. Companies in our database. You can also find out about relevant Phil Erlanger Research Co., Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record